Title Low Prevalence of Pneumocystis pneumonia ( PCP ) but High Prevalence of Pneumocystis dihydropteroate synthase ( dhps ) Gene Mutations in HIV-Infected Persons in Uganda Permalink
暂无分享,去创建一个
S. Meshnick | A. Cattamanchi | W. Worodria | Laurence Huang | S. Yoo | A. Andama | P. Byanyima | S. Kaswabuli | S. Taylor | C. Goodman | J. L. Davis
[1] S. Meshnick,et al. Low prevalence of Pneumocystis jirovecii lung colonization in Ugandan HIV-infected patients hospitalized with non-Pneumocystis pneumonia. , 2012, Diagnostic microbiology and infectious disease.
[2] M. Molyneux,et al. Etiology of suspected pneumonia in adults admitted to a high-dependency unit in Blantyre, Malawi. , 2011, The American journal of tropical medicine and hygiene.
[3] O. Matos,et al. Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations. , 2010, Parasite.
[4] P. Francioli,et al. Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] P. Hopewell,et al. Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients , 2010, European Respiratory Journal.
[6] A. Cattamanchi,et al. The Prevalence and Clinical Course of HIV-Associated Pulmonary Cryptococcosis in Uganda , 2010, Journal of acquired immune deficiency syndromes.
[7] J. Frean,et al. High Prevalence of Dihydropteroate Synthase Mutations in Pneumocystis jirovecii Isolated from Patients with Pneumocystis Pneumonia in South Africa , 2010, Journal of Clinical Microbiology.
[8] D. Stark,et al. Clinical Significance and Phylogenetic Relationship of Novel Australian Pneumocystis jirovecii Genotypes , 2009, Journal of Clinical Microbiology.
[9] N. H. Duc,et al. Clinical features and etiology of pneumonia in acid-fast bacillus sputum smear-negative HIV-infected patients hospitalized in Asia and Africa , 2008, AIDS.
[10] M. Mungthin,et al. Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-infected patients. , 2008, Medical mycology.
[11] G. Kibiki,et al. Aetiology and presentation of HIV/AIDS-associated pulmonary infections in patients presenting for bronchoscopy at a referral hospital in northern Tanzania. , 2008, East African medical journal.
[12] G. Fantoni,et al. Genotyping of Pneumocystis jiroveci Pneumonia in Italian AIDS Patients: Clinical Outcome Is Influenced by Dihydropteroate Synthase and Not by Internal Transcribed Spacer Genotype , 2007, Journal of acquired immune deficiency syndromes.
[13] S. Clarke,et al. Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda , 2007, Malaria Journal.
[14] A. Worku,et al. Pneumocystis jiroveci pneumonia and other pulmonary infections in TB smear-negative HIV-positive patients with atypical chest X-ray in Ethiopia , 2007, Scandinavian journal of infectious diseases.
[15] Marina C Costa,et al. Genetic characterization of the dihydrofolate reductase gene of Pneumocystis jirovecii isolates from Portugal. , 2006, The Journal of antimicrobial chemotherapy.
[16] H. Zar,et al. Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens. , 2006, Diagnostic microbiology and infectious disease.
[17] C. Beard,et al. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations , 2005, AIDS.
[18] S. Meshnick,et al. Mutations in the Pneumocystis jirovecii DHPS Gene Confer Cross-Resistance to Sulfa Drugs , 2005, Antimicrobial Agents and Chemotherapy.
[19] Jacques Bille,et al. Mutations of Pneumocystis jirovecii Dihydrofolate Reductase Associated with Failure of Prophylaxis , 2004, Antimicrobial Agents and Chemotherapy.
[20] S. Meshnick,et al. Sulfa Use, Dihydropteroate Synthase Mutations, and Pneumocystis jirovecii Pneumonia , 2004, Emerging infectious diseases.
[21] H. Zar,et al. Prevalence of dihydropteroate synthase mutants in HIV-infected South African children with Pneumocystis jiroveci pneumonia. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] P. Hauser,et al. Pneumocystis jiroveci Dihydropteroate Synthase Polymorphisms Confer Resistance to Sulfadoxine and Sulfanilamide in Saccharomyces cerevisiae , 2004, Antimicrobial Agents and Chemotherapy.
[23] W. Worodria,et al. Causes of lower respiratory infection in HIV-infected Ugandan adults who are sputum AFB smear-negative. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[24] J. Kovacs,et al. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. , 2002, The Journal of infectious diseases.
[25] C. Beard,et al. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study , 2001, The Lancet.
[26] C. Beard,et al. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. , 2000, The Journal of infectious diseases.
[27] S. Meshnick,et al. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. , 2000, The Journal of infectious diseases.
[28] J. Kovacs,et al. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. , 1999, The Journal of infectious diseases.
[29] J. Lundgren,et al. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P carinii pneumonia , 1999, The Lancet.
[30] J. Ioannidis,et al. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens. , 1996, Archives of internal medicine.
[31] A. Malin,et al. Pneumocystis carinii pneumonia in Zimbabwe , 1995, The Lancet.
[32] J. Bogaerts,et al. Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology. , 1994, American journal of respiratory and critical care medicine.
[33] P. Girard,et al. Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. , 1993, The American review of respiratory disease.
[34] P. Cregan,et al. Comparison of four methods for rapid detection of Pneumocystis carinii in respiratory specimens , 1990, Journal of clinical microbiology.
[35] P. Hopewell,et al. Evaluation of an indirect fluorescent-antibody stain for detection of Pneumocystis carinii in respiratory specimens , 1990, Journal of clinical microbiology.